tradingkey.logo
tradingkey.logo
Buscar

Rapid Micro Biosystems Inc

RPID
Añadir a la lista de seguimiento
2.070USD
-0.250-10.78%
Cierre 05/15, 16:00ETCotizaciones retrasadas 15 min
94.74MCap. mercado
PérdidaP/E TTM

Rapid Micro Biosystems Inc

2.070
-0.250-10.78%

Más Datos de Rapid Micro Biosystems Inc Compañía

Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.

Información de Rapid Micro Biosystems Inc

Símbolo de cotizaciónRPID
Nombre de la empresaRapid Micro Biosystems Inc
Fecha de salida a bolsaJul 15, 2021
Director ejecutivoSpignesi (Robert)
Número de empleados163
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 15
Dirección25 Hartwell Avenue
CiudadLEXINGTON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal02421
Teléfono19783493200
Sitio Webhttps://www.rapidmicrobio.com/
Símbolo de cotizaciónRPID
Fecha de salida a bolsaJul 15, 2021
Director ejecutivoSpignesi (Robert)

Ejecutivos de Rapid Micro Biosystems Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+12.88%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+37.05%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
29.44K
+2.86%
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. John Wilson
Mr. John Wilson
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Kirk D. Malloy, Ph.D.
Dr. Kirk D. Malloy, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. James Xu
Mr. James Xu
Senior Vice President - Legal, Company Secretary
Senior Vice President - Legal, Company Secretary
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+12.88%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+37.05%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
29.44K
+2.86%
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Product revenue
23.43M
69.75%
Service revenue
10.16M
30.25%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
13.43M
39.99%
Switzerland
6.02M
17.92%
All other countries
5.77M
17.18%
Germany
5.77M
17.17%
Japan
2.60M
7.73%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Product revenue
23.43M
69.75%
Service revenue
10.16M
30.25%

Estadísticas de accionistas

Actualizado: jue., 14 de may
Actualizado: jue., 14 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Bain Capital Life Sciences Investors, LLC
20.44%
Kennedy Lewis Investment Management LLC
11.97%
Longitude Capital Management Co., LLC
8.62%
Endeavour Medtech Growth II LP
5.47%
Ally Bridge Group (HK) Limited
4.48%
Otro
49.02%
Accionistas
Accionistas
Proporción
Bain Capital Life Sciences Investors, LLC
20.44%
Kennedy Lewis Investment Management LLC
11.97%
Longitude Capital Management Co., LLC
8.62%
Endeavour Medtech Growth II LP
5.47%
Ally Bridge Group (HK) Limited
4.48%
Otro
49.02%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
37.20%
Venture Capital
9.88%
Investment Advisor/Hedge Fund
6.28%
Corporation
5.47%
Individual Investor
4.45%
Hedge Fund
3.07%
Private Equity
1.40%
Research Firm
0.54%
Pension Fund
0.06%
Otro
31.65%

Participación institucional

Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
67
25.08M
60.78%
+607.83K
2025Q4
59
23.36M
58.78%
-1.87M
2025Q3
56
23.72M
59.74%
-1.53M
2025Q2
68
28.04M
71.29%
+1.90M
2025Q1
76
27.59M
71.01%
+589.97K
2024Q4
81
24.48M
63.27%
-5.50M
2024Q3
105
26.74M
70.33%
-7.92M
2024Q2
116
27.58M
73.05%
-8.07M
2024Q1
141
28.00M
74.27%
-11.17M
2023Q4
153
28.87M
77.88%
-11.80M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Bain Capital Life Sciences Investors, LLC
8.43M
20.59%
--
--
Dec 31, 2025
Kennedy Lewis Investment Management LLC
4.94M
12.06%
--
--
Sep 30, 2024
Longitude Capital Management Co., LLC
4.08M
9.96%
-55.00K
-1.33%
Feb 03, 2026
Endeavour Medtech Growth II LP
2.26M
5.51%
--
--
Dec 31, 2025
Ally Bridge Group (HK) Limited
1.85M
4.51%
--
--
Dec 31, 2025
Spignesi (Robert G JR)
693.23K
1.69%
-17.92K
-2.52%
Mar 10, 2026
Advent International L.P.
577.78K
1.41%
--
--
Dec 31, 2025
Evernest Financial Advisors, LLC
125.00K
0.31%
-75.23K
-37.57%
Dec 31, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares Micro-Cap ETF
0.02%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
Proporción0.02%
Dimensional US Core Equity 1 ETF
Proporción0%
Avantis US Small Cap Equity ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI